Skip to main content
HONZ PHARMACEUTICAL CO., LTD. logo

HONZ PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 300086 ISIN · CNE100000QM6 LEI · 300300SA7ZULJ816T861 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,012 across all filing types
Latest filing 2018-06-25 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300086

About HONZ PHARMACEUTICAL CO., LTD.

https://www.honz.com.cn

HONZ Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical products, with a specialized emphasis on pediatric healthcare. The company provides a diverse range of medications specifically formulated for children, including antipyretics, analgesics, respiratory treatments, and anti-infective agents. It utilizes advanced drug delivery systems and taste-masking technologies to enhance patient compliance and therapeutic efficacy. In addition to its pediatric portfolio, the organization produces various chemical drugs and traditional Chinese medicine preparations. The company maintains multiple production bases and research centers dedicated to advancing clinical solutions and ensuring high standards of product quality across its therapeutic categories.

Recent filings

Filing Released Lang Actions
第四届监事会第十四次会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of the resolution from the 14th meeting of the 4th Supervisory Board of Kangzhi Pharmaceutical Co., Ltd. It includes details about the election of the Supervisory Board Chairman and a brief biography of the elected individual. The content is about board/management changes and does not contain financial statements or detailed financial data. The document length is short (925 characters), and it is a formal announcement of a board decision rather than a full report or presentation. Therefore, it fits the category of Board/Management Information (MANG).
2018-06-25 Chinese
2017年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the legality and validity of the 2017 Annual General Meeting (AGM) of 康芝药业股份有限公司. It details the procedures of the AGM, including the convening, attendance, agenda items, voting procedures, and results. The document does not contain the actual annual report or financial statements but rather confirms the legality of the AGM and its resolutions. This type of document is typically classified as a Declaration of Voting Results & Voting Rights Announcements (DVA) because it reports on the official voting outcomes and the validity of the meeting proceedings. The document length (8362 characters) and content confirm it is not a brief announcement but a detailed legal opinion on the AGM voting results. Therefore, the appropriate classification is DVA with high confidence.
2018-06-22 Chinese
关于收购广州瑞瓴网络科技有限责任公司100%股权以间接持有云南九洲医院有限公司51%股权及昆明和万家妇产医院有限公司51%股权的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of an acquisition transaction by 康芝药业股份有限公司 (Kangzhi Pharmaceutical Co., Ltd.). It details the completion of the acquisition of 100% equity of Guangzhou Ruiling Network Technology Co., Ltd., which indirectly holds stakes in two hospitals. The document includes specifics about the new business license and registration details. There is no financial report, earnings data, or detailed management discussion. The document is a corporate announcement about a capital transaction (acquisition) and progress update, not a full merger filing or tender offer document. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short (1003 characters), and it is not merely an announcement of a report but a substantive update on a financing-related transaction.
2018-06-22 Chinese
公司章程（2018年6月）
Governance Information Classification · 100% confidence The document is titled as the "公司章程" which translates to "Articles of Association" or "Company Bylaws." It contains detailed provisions about the company's organizational structure, shareholder rights, board of directors, management, financial accounting, profit distribution, auditing, and procedures for shareholder meetings. It references laws such as the Company Law of the People's Republic of China and Securities Law, and includes detailed governance rules and procedures for meetings, voting, and management responsibilities. There is no indication that this is a financial report, earnings release, or announcement of voting results. Instead, it is a governance document outlining the internal rules and governance practices of the company. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and content confirm it is a full governance report, not a brief announcement or certification.
2018-06-22 Chinese
关于股价异动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding abnormal stock price fluctuations of the company 康芝药业股份有限公司 (Kangzhi Pharmaceutical Co., Ltd.) over a specific period in June 2018. It includes explanations about the stock price movements, verification of information disclosure compliance, and risk warnings to investors. The document does not contain financial statements, detailed financial performance data, or management discussion and analysis. It is a regulatory announcement addressing stock price abnormality and compliance with disclosure rules, typical of a regulatory filing to inform the market and investors. The document length is short (1518 characters), and it is not a report or presentation but a formal announcement. Therefore, the appropriate classification is Regulatory Filings (RNS).
2018-06-22 Chinese
2017年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2017 Annual General Meeting Resolution Announcement" for Kangzhi Pharmaceutical Co., Ltd. It details the date and method of the AGM, attendance, voting results on various proposals including the 2017 annual report, financial statements, profit distribution, and election of a supervisor. It also includes legal opinions confirming the validity of the meeting and resolutions. The content is focused on the official announcement of the shareholder meeting resolutions and voting outcomes rather than the full annual report or financial statements themselves. The document length is about 5,067 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2018-06-22 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.